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Abstract: 
Background: According to an idea, a relationship between non-alcoholic greasy liver ailment (NAFLD) and serum 
nutrient D levels exist. Be that as it may, the unequivocal job and instruments are obscure. 
Objective: To study serum vitamin D levels in patients with NAFLD was the aim of this study.  
Place and Time of Study: Services hospital, Lahore from Feb 2018 to Jan 2019.  
Methods: Analysis of NAFLD depends on ultrasound (U.S) discoveries after prohibition of other potential reasons 
for NAFLD and interminable liver infections. For this investigation, fifty patients with NAFLD and another 50 solid 
volunteers without NAFLD or any clinically clear liver ailments were enlisted. Serum 25(OH) nutrient D levels were 
estimated utilizing ELISA based test. 
Results: Serum 25 (OH) nutrient D levels is conversely connected with weight list (BMI), all out cholesterol, 
triglycerides, low thickness lipoprotein (LDL) and age. There is measurably critical diminishing of serum 25(OH) 
nutrient D levels in patients with NAFLD than those without NAFLD. 
Conclusion: It is concluded that Serum 25(OH) vitamin D level and NAFLD has inverse relation.  
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INTRODUCTION: 
NAFLD has the probability of movement to non-
alcoholic steatohepatitis (NASH), cirrhosis and 
hepatocellular carcinoma (HCC). The accurate 
instrument of NAFLD advancement is obscure. 
NAFLD is the most widely recognized liver infection 
in western countries [1]. It is normally connected with 
insulin obstruction and metabolic syndrome [2-3]. 
Nutrient D may have a job being developed of immune 
system ailments and provocative conditions through 
creation of incendiary cytokines. Nutrient D has 
numerous capacities in numerous frameworks of the 
human body, including muscles, bone, heart, gut, liver 
and safe framework [4-7]. An expanding proof is 
indicating a nearby connection between 25 (OH) 
nutrients D and NAFLD. A few examinations found a 
noteworthy relationship between nutrient D 
insufficiency and heftiness, metabolic disorder, type 
2diabetes and insulin resistance [6-8]. Along these 
lines, to explore the conceivable relationship among 
NAFLD and serum 25(OH) nutrient D levels was the 
point of this examination. 
 
METHODS: 
We selected 50 patients with NAFLD (cases), and 50 
sound volunteers without NAFLD or any ceaseless 
liver infection as controls, cross coordinated with 
patients in age and sex. This investigation is a cross 
sectional examination. It was carried out in order to 
examine the relationship among NAFLD and serum 
25(OH) nutrient D. 
 
Inclusion criteria: 
All the patients selected were 18 years and above. All 
participants were the patients of NAFLD. 
Detailed history, clinical examination and BMI 
calculation were done for every patient. All subjects 
(cases and controls) are admitted to Services hospital, 
Lahore. 
 
Exclusion criteria: 
The Patients with Wilson’s disease or 
hemochromatosis were not selected for the study.  
Patients with renal failure and clinical, radiological or 
laboratory evidence of chronic liver disease were 
excluded. Patients who are taking drugs contain or 
affecting vitamin D level including: pure vitamin D 
drugs or multivitamins containing vitamin D formulas 
were expelled. People with hepatitis B or C infection 
and Alcohol users: daily consumption of more than 20 
grams for males and 10 grams for females were not 
selected. This study does not include children.  
 
Laboratory evaluation: 
After a mid-night fasting, laboratory tests such as 
fasting blood sugar, lipid profile, complete blood 
count, liver functions (AST, ALT, serum bilirubin, 
INR, total protein and albumin) and renal function 
were carried out for all the patients. 
 
Assessment of NAFLD: 
Ultrasound examination was finished utilizing a B-
mode arched test from 2.5-5 MHz on a Mindray DP-
2200 ultrasound machine (Shenzhen, China). Finding 
of NAFLD was finished relying upon ultrasound 
imaging of the liver [9]. NAFLD was reviewed on a 
scale from 0-3 as indicated by Saverymuttu et al [10], 
where 0 is alludes to nonappearance of NAFLD, 1 
mellow, 2 moderate and 3 serious NAFLD. Ultrasound 
examination was finished by a similar administrator - 
who was visually impaired for the consequences of 
research center information and serum 25 (OH) 
nutrient D levels-for each subject around the same 
time of clinical examination and lab appraisal. 
 
Vitamin D level: 
Serum is isolated. It is put away in - 25℃ for couple 
of days. It is an ELISA based test. By utilizing The 
Algeria 25-OH Vitamin D3/D2 Test Strip 
(ORGENTEC Diagnostika GmbH Carl-Zeiss-Straβe 
49-51 Mainz – Germany), 25(OH) nutrient D levels 
were estimated. 
 
Ethical consideration: 
Verbal assent was taken from people who took an 
interest in the examination. Servises hospital-Faculty 
of drug moral board of trustees endorsed the 
investigation. 
 
Statistical analysis: 
Multivariable direct relapse examination was 
performed to distinguish free hazard elements of 
nutrient D. Gauge statistic, clinical, and research 
center qualities were recorded as numbers and rate for 
clear cut information and means and standard 
deviation for constant information. Understudy's T-
test was utilized to think about aftereffects of constant 
factors among gatherings and chi square test for 
straight out factors. P-esteem thought about 
noteworthy if < 0.05. Measurable investigation was 
finished utilizing SPSS form 22 (IBM SPSS Inc., 
Chicago, US) for windows 10. 
 
RESULTS: 
Grade 1 NAFLD was available in 13 patients (26%), 
grade 2 out of 24 patients (48%), and grade 3 out of 13 
patients (26%). Pattern attributes of patients and 
control were surrendered (Table 1). No noteworthy 
contrasts among guys and females in serum 25(OH) 
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nutrient D levels (Table 2). Patients with NAFLD 
demonstrated higher white platelet tally, BMI, fasting 
glucose (FBS), ALT, triglycerides and absolute 
cholesterol levels than controls. 
 
Table 1: Baseline characteristics of cases and controls. 
 Cases (n = 50)  
Mean ± SD 
Control (n = 50) 
Mean ± SD 
P- value 
Age (years) 49.88 ± 9.126 47 ± 8.769 0.374 
Males/Females  27/23 26/24 0.886 
BMI (Kg/m²) 26.18 ± 4.03 23.41 ± 2.64 0.045 
HB (g/dl)  12.11 ± 1.44 11.99 ± 1.033 0.809 
RBCs (106 cells/mm3)  4.64 ± 0.55 4.48 ± 0.64 0.453 
WBCs (103/mm3)  7.69 ± 1.92 6.13 ± 1.28 0.019 
Platelets (103/mm3)  266.08 ± 74.35 282 ± 59.48 0.533 
FBS (mg/dl) 135.28 ± 93.51 93.50 ± 19.89 0.013 
ALT (U/L) 54.42 ± 36.79  24.46 ± 10.43 0.008 
AST (U/L)  43.97 ± 27.53 27.30 ± 9.32 0.067 
Albumin (g/dl)  4.23 ± 0.34 4.02 ± 0.21 0.07 
Total protein (g/dl)  6.99 ± 0.67 6.79 ± 0.69 0.409 
Total bilirubin (mg/dl)  0.61 ± 0.24 0.51 ± 0.23 0.242 
TG (mg/dl)  200.25 ± 140.13 74.70 ± 34.74 0.008 
Cholesterol (mg/dl)  215.38 ± 50.81 150.30 ± 29.37 0 
LDL (mg/dl)  131.94 ± 33.42 145.12 ± 42.37 0.296 
HDL (mg/dl)  54.39 ± 17.41 54.70 ± 15.05 0.959 
INR  1.03 ± 0.09 1.06 ± 0.15 0.496 
Creatinine (mg/dl)  0.79 ± 0.28 0.77 ± 0.25 0.879 
Vitamin D 18.76 ± 14.37 40.36 ± 22.24 0 
. 
 
 
BMI: body mass index, HB: Hemoglobin, RBCs: red blood cells, WBCs: white blood cells, FBS: fasting blood sugar, 
ALT: alanine transferase, AST: Aspartate transferase, TG: Triglycerides, LDL: low density lipoprotein, HDL: high 
density lipoprotein, INR: international normalized ratio. 
 
NAFLD and 25(OH) vitamin D: 
Complete cholesterol levels were conversely 
connected with serum 25(OH) nutrient D levels and 
LDL levels were emphatically connected with serum 
25(OH) nutrient D levels, generally no different 
elements influencing serum nutrient D levels. Serum 
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25 (OH) nutrients D levels were essentially decreased 
in patients with NAFLD than those without NAFLD 
(18.76 versus 40.36 p esteem 0.000) (Table 1). No 
noteworthy distinction in serum 25 (OH) nutrient D 
levels between patients with grade 1 NAFLD and 
those without NAFLD. Then again, there are 
noteworthy contrasts between patients with grade 2 
and 3 on one hand and those with grade 1 and 0 then 
again. Serum 25(OH) nutrient D levels diminished 
with the expansion in the NAFLD grade (Table 3). 
Multivariable direct relapse investigation was utilized 
to evaluate indicators of serum 25 (OH) nutrients D 
(Table 4). 
 
DISCUSSION: 
Patients in our investigation had typical engineered 
work, with no huge contrasts between NAFLD 
patients and control bunch in egg whites, INR or 
bilirubin levels. Along these lines, low dimensions of 
25 (OH) nutrients D in NAFLD bunch in our 
examination isn't because of manufactured inadequacy 
of nutrient D by the liver. 
 
Table 2: Vitamin D levels in males and females. 
Vitamin D (ng/dL) Mean ± SD P- value 
Sex 
Female 20.45 ± 16.42 
0.234   
 Male 24.71 ± 20.27  
 
 
 
Table 3 Vitamin D levels according to U.S grades of NAFLD. 
 Grade 0 (50) Grade 1 (13) Grade 2 (24) Grade 3 (13) 
Vitamin 
D level 
40.36 ± 22.24 a 35.56 ± 20.83 a 13.39 ± 2.06 b  12.74 ± 5.56 b  
0
0.05
0.1
0.15
0.2
0.25
20.45 ± 16.42 24.71 ± 20.27
FEMALE MALE
SEX
0.234
Table 2 Vitamin D levels in males and 
females. P- value
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a, b: there are significant differences between groups with different letters but not among groups with the same letter. 
Table 4 Multivariable linear regression analysis of determinants of vitamin D level, Dependent variable: vitamin D. 
Determinant B S. E Beta P-value 
Age -0.245 0.284 -0.121 0.395 
BMI -1.274 0.697 -0.281 0.075 
FBS -0.034 0.044 -0.16 0.447 
TC -0.144 0.055 -0.435 0.013 
HDL -71 0.156 -0.067 0.65 
LDL 0.203 0.07 0.401 0.006 
TG 0.021 0.03 0.157 0.493 
 
 
Vitamin D level
0
0.5
1
Grade 0 (50)
Grade 1 (13)
Grade 2 (24)
Grade 3 (13)
Vitamin D level
B
Age BMI FBS TC HDL LDL TG
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BMI: body mass index, FBS: fasting blood sugar, TC: total cholesterol, HDL: high density lipoproteins, LDL: low 
density lipoprotein, TG: triglycerides 
Table 5 correlation between Age & sex and mean vitamin D levels. 
 Vitamin  D (ng/dl) 
R P- value 
Age (years) -0.3 0.034 
BMI (kg/m2) -0.186 0.01 
 
 
BMI: body mass index. 
 
Table 6 Correlation between laboratory data and mean Vitamin D levels. 
 Vit.D(ng/dl) 
r P- value 
HB (g/dl)  0.223 0.12 
Glucose (mg/dl) -0.232 0.109 
ALT (U/L) -0.383 0.006 
AST (U/L)  -0.409 0.003 
Serum albumin (g/dl)  -0.037 0.8 
Total protein (g/dl)  -0.025 0.862 
Total bilirubin (mg/dl)  0.056 0.7 
TG (mg/dl)  -0.324 0.022 
Cholesterol (mg/dl)  -0.309 0.029 
LDL (mg/dl)  0.329 0.02 
HDL (mg/dl)  0.176 0.22 
Serum creatinine (g/dl) -0.031 0.83 
-62%
-38%
Vitamin  R
Age (years)
BMI (kg/m2)
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HB: hemoglobin, ALT: alanine transferase, AST: 
aspartate transferase, TG: triglycerides, LDL: low 
density lipoprotein, HDL: high density lipoprotein is 
expected to decrease due to synthetic dysfunction of 
the liver[11]. However, patients in our study had 
normal synthetic function, with no significant 
differences between NAFLD patients and control 
group in albumin, INR or bilirubin levels. So, low 
levels of 25 (OH) vitamin D in NAFLD group in our 
study is not due to synthetic deficiency of vitamin D 
by the liver. Also, vitamin D deficiency may induce 
NAFLD by impairing hepatic lipid metabolism[12]. 
Patients with vitamin D deficiency found to have high 
rates of insulin resistance, metabolic syndrome and 
inflammatory mediators including IL-4, IL-6 and 
TNF-α[13,14]. It was reported that vitamin D 
receptors widely exist in liver tissue with negative 
association between vitamin D receptors expression 
and necro-inflammatory grades of NASH[15]. 
Vitamin D may be sequestrated in the adipose tissue in 
obese patients[16]. Also, NAFLD patients may have a 
sedentary life with low sunlight exposure and 
nutritional imbalance. 
 
Additionally, nutrient D lack may prompt NAFLD by 
disabling hepatic lipid metabolism [12]. The 
component by which 25 (OH) nutrients D may prompt 
NAFLD isn't clear. The liver proselytes’ nutrient D to 
its dynamic structure, 25 (OH) nutrients D, so in liver 
maladies the 25 (OH) nutrient D levels is required to 
diminish because of manufactured brokenness of the 
liver [11]. In our investigation, patients with NAFLD 
demonstrated altogether diminished serum 25(OH) 
nutrient D levels than those without NAFLD. Serum 
25(OH) nutrient D levels were observed to be logically 
diminished with the expansion in the ultrasound 
grades of NAFLD. Nutrient D lack may prompt 
NAFLD by impeding hepatic lipid metabolism [12]. 
NAFLD patients may have a stationary existence with 
low daylight introduction and dietary lopsidedness. 
Patients with nutrient D lack found to have high rates 
of insulin opposition, metabolic disorder and fiery 
middle people including IL-4, IL-6 and TNF-α [13-
14]. It was accounted for that nutrient D receptors 
broadly exist in liver tissue with negative relationship 
between nutrient D receptors articulation and necro-
fiery levels of NASH [15]. Nutrient D might be 
sequestrated in the fat tissue in stout patients [16]. 
Barchetta et al [18] 2011, found solid relationship 
between hypovitaminosis D and NAFLD which was 
autonomous on age, sex, BMI, lipid profile or glucose 
level. Chung et al [19] 2016, found that serum nutrient 
D levels were corresponded contrarily with NAFLD in 
a portion subordinate way autonomously on known 
NAFLD hazard factors. Our outcomes are in 
concurrence with Targher et al [17] 2007 who 
discovered huge reduction of nutrient D levels in 
patients with NAFLD than sound controls, which was 
related with NAFLD histo-pathological highlights. In 
our examination, nutrient insufficient patients (serum 
nutrient D under 20 mg/mL[20]) were fundamentally 
more established in age, more were females, with 
essentially higher aminotransferases levels than 
typical nutrient D subjects (serum nutrient D in excess 
of 30 mg/mL[20]). They additionally have essentially 
more elevated amounts of triglycerides and absolute 
cholesterol than subjects with typical dimensions of 
nutrient D (Table 8). Nelson et al [20] 2016, found that 
low dimensions of nutrient D are related with high 
danger of NASH in patients with NAFLD. Our 
Table 6 Correlation between laboratory data 
and mean Vitamin D levels. Vit.D(ng/dl) r
HB (g/dl)
Glucose (mg/dl)
ALT (U/L)
AST (U/L)
Serum albumin (g/dl)
Total protein (g/dl)
Total bilirubin (mg/dl)
TG (mg/dl)
Cholesterol (mg/dl)
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outcomes are likewise in concurrence with Zhai et al 
[21] 2016, Wang et al [22] 2016, Yang et al [23] 2017 
and Eliades et al [8] meta-examination 2013 who 
revealed that nutrient D inadequate patients have 1.26-
overlay expanded hazard for NAFLD than those with 
adequate nutrient D. In any case, our outcomes are in 
opposite with Li et al [24] 2013, who found no 
noteworthy contrasts between patients with NAFLD 
and those without NAFLD in serum nutrient D levels. 
Additionally, Patel et al [25] 2016, Ha et al [26] 2017, 
De Paula et al [27] 2017 and Park et al [28] 2017 found 
no relationship between nutrient D levels and NAFLD 
(Table 7 abridges these investigations).  
 
Table 7 summary of studies results on vitamin D in NAFLD patients. 
Study  NAFLD Controls  P- value 
Targher et al 2007 51.0 ± 22  74.5 ± 15 < 0.001 
Barchetta et al 2011 14.8 ± 9.2 20.5 ± 9.7 < 0.001 
Chung et al 2016 21.75 ± 7.54 22.02 ± 8.43  0.253 
Zhai et al 2016 40·05 ± 9.83 40.98 ± 10.80 < 0.01 
Yang et al 2017 16.63 ± 6.57 18.44 ± 7.30 0.011 
Eliades et al 2013 
meta-analysis  
Reported that vitamin D deficient patients have 1.26-fold 
increased risk for NAFLD than vitamin D sufficient 
patients 
Li et al 2013 22.8 ± 8.4 22.1 ± 8.1 0.21 
Patel et al 2016 27.9 ± 12.8 27.7 ± 11.9 0.878 
Ha et al 2017 16.2 ± 6.2 16.2 ± 6.5 0.95 
De Paula et al 2017 
Steatosis NASH 
28.66 ± 8.40 0.55   
 27.6 ± 
12.49 
26.5 ± 
7.38 
  
Park et al 2017 21.8 ± 8.7 21.5 ± 8.1 0.151 
 
 
 
 
 
 
 
0.253 0 0.011 0.21
0.878
0.95
0.55
0.151
Table 7 summary of studies results on 
vitamin D in NAFLD patients. P- value 
< 0.001 < 0.001
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Table 8 Characteristics of the study participants according to serum 25 ( OH) vitamin D state. 
 NVD VDD P value 
Age  45.37 ± 9.13 51.71 ± 8.22 0.014 
Sex (male/female) 25/15 28/32 0 
BMI 24.73 ± 2.68 26.17 ± 4.49 0.213 
ALT 28.42 ± 17.81 61.98 ± 34.96 0 
AST 25.70 ± 11.24 49.79 ± 27.96 0.001 
Bilirubin 0.58 ± 0.23 0.59 ± 0.24 0.813 
Albumin  4.17 ± 0.26 4.19 ± 0.37 0.856 
Total protein 6.90 ± 0.66 6.98 ± 0.69 0.687 
FBS 103.00 ± 48.59 140.55 ± 98.92 0.139 
TG 112.00 ± 82.00 213.84 ± 148.28 0.009 
Total cholesterol 168.84 ± 35.30 222.90 ± 53.37 0 
LDL 145.43 ± 32.29 127.92 ± 35.93 0.089 
HDL 57.30 ± 16.36 52.71 ± 17.12 0.354 
INR 01.04 ± 0.11 1.03 ± 0.10 0.946 
Creatinine 0.82 ± 0.25 0.77 ± 0.28 0.53 
HB 12.38 ± 1.21 11.90 ± 1.43 0.228 
Platelets  284.74 ± 68.66 259.77 ± 72.41 0.234 
WBCs 6.76 ± 1.33 7.75 ± 2.12 0.077 
RBCs 4.56 ± 0.56 4.64 ± 0.58 0.64 
 
 
NVD: normal vitamin D, VDD: vitamin D deficiency, BMI: body mass index, ALT: alanine transferase, AST: 
aspartate transferase, FBS: fasting blood sugar, TG: triglycerides, LDL: low density lipoprotein, HDL: high density 
lipoprotein, INR: international normalized ratio, HB: hemoglobin, WBCs: white blood cells, RBCs: red blood cells. 
 
These conflicting outcomes among studies might be 
identified with contrasts in the examined populace, 
wholesome and ecological components. 
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